Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy Collaborative Group Academic Article uri icon

Overview

MeSH Major

  • Prostate
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • External validation of the PCPTRC across ten cohorts revealed varying degree of success highly dependent on the cohort, most likely due to different criteria for and work-up before biopsy. Future validation studies of new calculators for prostate cancer should acknowledge the potential impact of the specific cohort studied when reporting successful versus failed validation.

publication date

  • April 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3616370

Digital Object Identifier (DOI)

  • 10.1007/s00345-011-0818-5

PubMed ID

  • 22210512

Additional Document Info

start page

  • 181

end page

  • 7

volume

  • 30

number

  • 2